Cost-effectiveness of Canagliflozin versus Sitagliptin when Added to Metformin and Sulfonylurea in Type 2 Diabetes in Canada
Våra senaste publiceringar
Publicering / Kostnader och sjukdomsbörda
Modelling the wider socio-economic costs of opioid dependence in the UK
Publicering / Policy
Genomic Medicine Sweden: Advancing precision medicine at the national level
Publicering / Policy